A. Hillary Steinhart, MD, MSc., FRCP(C)

Director of Clinical Trials
Mount Sinai Hospital IBD Centre
Professor of Medicine
University of Toronto


Iain Murray, MD, CM, FRCP(C)

Intestinal Health Institute
Past President, OAG

Sunday, November 20, 2022

7:30 am - 8:30 am

A Look At The Future Use of Anti-TNFs in IBD

Learning Objectives: 

  1. Review the clinical use of anti-TNF biologics in inflammatory bowel disease (IBD) clinical practise 
  2. Provide an update on the most recent data on biosimilars and their use in IBD
  3. Understand the concept of biosimilars and their potential impact on the future use of anti-TNF agents

Dr. Hillary Steinhart is a Professor of Medicine in the Department of Medicine at the University of Toronto. He also holds a faculty appointment at the Institute of Health Policy, Management and Evaluation at the University of Toronto. From 2000 to 2015 he was Head of the Combined Division of Gastroenterology at Mount Sinai Hospital and University Health Network in Toronto and was the Medical Lead of the Inflammatory Bowel Disease Centre at Mount Sinai Hospital from 2015 to 2018.

Dr. Steinhart has had a very active medical practice for over 30 years. Over most of that time, his efforts have been focused almost exclusively on caring for patients with inflammatory bowel disease and he has a very large practice of patients with Crohn’s disease and ulcerative colitis.

Dr. Steinhart’s research interests include the evaluation of new therapeutic strategies for the treatment of inflammatory bowel disease, meta-analysis and clinical trials methodology, disease severity evaluation and complications of inflammatory bowel. He has published over 180 research papers as well as two books on Inflammatory Bowel Disease for patients and families.

Dr. Steinhart is a past chair of the Crohn’s and Colitis Canada’s Scientific and Medical Advisory Committee and a former recipient of that Foundation’s Research Leadership Award.

Dr. Iain Murray lead a dull existence until one day in 2014 when he became President of the OAG.  He had three fun years of presidency, and five exhilarating years as OMA Section Chair for Gastroenterology.  These heady days are now over, and he is now living a quiet, sedate life taking care of GI patients at the Intestinal Health Institute in Markham.

Sponsored by: